ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,427, issued on Aug. 26, was assigned to ST. JOHN'S UNIVERSITY (Queens, N.Y.).
"Circulating serum microRNA biomarkers and methods for Alzheimer's disease diagnosis" was invented by Simon Geir Moller (Queens, N.Y.), Ketan Shirish Patil (Queens, N.Y.) and Guido Werner Alves (Stavanger, Norway).
According to the abstract* released by the U.S. Patent & Trademark Office: "Biomarkers and methods for identifying, verifying and confirming circulating serum-based microRNAs. The microRNAs (PARKmiRs) can be used to differentiate patient's suffering from Alzheimer's disease (AD) from non-AD patients."
The patent was filed on March 13, 2023, under Application No. 18/182,868.
*For further inf...